Brainsway Ltd. is a leading developer of innovative medical devices specialized in non-invasive neuromodulation therapies targeting neurological and psychiatric disorders. Based in Jerusalem, Israel, the company's flagship Deep TMS (Transcranial Magnetic Stimulation) system is recognized for its effectiveness in addressing pressing unmet medical needs worldwide. With a robust focus on research and development, Brainsway aims to improve patient outcomes while positioning itself as a key player in the expanding neuromodulation market. The company’s strategic endeavors to broaden clinical applications and enhance its product portfolio are poised to drive significant growth within the dynamic healthcare sector. Show more
Location: 16 HARTUM ST, JERUSALEM, ISRAEL, 9777516, Jerusalem, 9777516, USA | Website: https://www.brainsway.com | Industry: MEDICAL DEVICES | Sector: HEALTHCARE
Market Cap
414.8M
52 Wk Range
$7.84 - $25.65
Previous Close
$20.93
Open
$21.29
Volume
32,016
Day Range
$20.96 - $21.95
Enterprise Value
369M
Cash
70.46M
Avg Qtr Burn
N/A
Insider Ownership
6.17%
Institutional Own.
31.18%
Qtr Updated
09/30/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
